The profitability of CG Oncology, Inc. over the past 3 years
Chart CG Oncology, Inc.: operating income, net income, fiscal 2023–2025 Open the chart →CG Oncology, Inc. reported a net loss of $161M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $190.77M. It reported a loss in all 3 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$190.77M | -$161M |
| 2024ended Dec 31, 2024 | -$114.67M | -$88.04M |
| 2023ended Dec 31, 2023 | -$55.45M | -$48.61M |
Fiscal years as CG Oncology, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on CG Oncology, Inc.
- The revenue of CG Oncology, Inc.
- The debt of CG Oncology, Inc.
- All of CG Oncology, Inc.'s financials, charted
Companies of a similar size
- ORAORMAT TECHNOLOGIES, INC.
- EXPEAGLE MATERIALS INC
- ANAUTONATION, INC.
- BXSLBlackstone Secured Lending Fund
- LAURLaureate Education, Inc.
Not investment advice. This page shows what CG Oncology, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.